Anti-cancer drugs bid at import expo
September 12, 2019
Leading pharmaceutical companies will be taking part in the second China International Import Expo in an effort to to introduce more anti-cancer drugs to the Chinese market.
Several enterprises, including Pfizer Biopharmaceuticals Group, Roche Pharmaceuticals and Merck Sharp & Dohme (MSD), introduced the drugs they will exhibit at November’s expo at a support session for its health care exhibition area.
Wu Kun, country lead of Pfizer China Biopharma, said the company will bring several medicines including Ibrance, a treatment for advanced-stage breast cancer.